Magdalena Kokoszka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Magdalena Kokoszka has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Grażyna Stryjewska-Makuch
Silesian Med Univ, Leszek Giec Uppersilesian Med Ctr, Dept Laryngol & Laryngol Oncol, Katowice, Poland
3 shared publications- Grażyna Stryjewska-Makuch
Department of Laryngology and Laryngological Oncology, Leszek Giec Upper-Silesian Medical Centre of the Silesian Medical University, 40-635 Katowice, Poland
2 shared publications Joanna Gluck
Slaski Uniwersytet Medyczny w Katowicach
2 shared publications- Joanna Glück
Clinical Department of Internal Diseases, Allergology and Clinical Immunology, Medical University of Silesia, 40-752 Katowice, Poland
2 shared publications Karolina Goroszkiewicz
Silesian Med Univ, Leszek Giec Uppersilesian Med Ctr, Dept Laryngol & Laryngol Oncol, Katowice, Poland
2 shared publicationsMagdalena Onyszczuk
Department and Chair of Pathomorphology, Faculty of Medical Sciences in Zabrze Medical University of Silesia Katowice Poland
2 shared publications
Latest Publications
- Open Access
- 28 January 2025
- Published by Wiley
Biological treatment of chronic rhinosinusitis with polyps increases number of nasal ciliated cells -- real-life experience
Chronic rhinosinusitis (CRS) is a complex, multifactorial inflammatory disease of the nasal mucosa and paranasal sinuses, in which disruption of the integrity of the mucosal barrier initiates an inflammatory cascade. It results, among other things, in the formation of polyps, increased secretion and impaired sense of smell. The aim of the study was to investigate the effect of biological treatment with mepolizumab or dupilumab on the cytological examination of the nasal mucosa in CRSwNP patients. The study included 23 patients who underwent cytological examinations at least 3 times during 6 months of treatment. 21 patients were treated for 9 months. Samples were evaluated at 400x magnification and expressed as the mean of 50 high-power microscopic fields (HPF) that had been assessed. Ciliated cells, goblet cells, plasma cells, neutrophils, eosinophils and mast cells were counted. All patients had their sense of smell tested every 3 months using a visual analogue scale (VAS). During biological treatment of CRSwNP patients with mepolizumab and dupilumab, cytological examinations revealed an increase in the number of ciliated cells, a decrease in the number of eosinophils correlated with an improvement in the sense of smell on the VAS scale.
- 28 January 2025
- Published by Wiley
Open AccessBiological treatment of chronic rhinosinusitis with polyps increases number of nasal ciliated cells -- real-life experience
Chronic rhinosinusitis (CRS) is a complex, multifactorial inflammatory disease of the nasal mucosa and paranasal sinuses, in which disruption of the integrity of the mucosal barrier initiates an inflammatory cascade. It results, among other things, in the formation of polyps, increased secretion and impaired sense of smell. The aim of the study was to investigate the effect of biological treatment with mepolizumab or dupilumab on the cytological examination of the nasal mucosa in CRSwNP patients. The study included 23 patients who underwent cytological examinations at least 3 times during 6 months of treatment. 21 patients were treated for 9 months. Samples were evaluated at 400x magnification and expressed as the mean of 50 high-power microscopic fields (HPF) that had been assessed. Ciliated cells, goblet cells, plasma cells, neutrophils, eosinophils and mast cells were counted. All patients had their sense of smell tested every 3 months using a visual analogue scale (VAS). During biological treatment of CRSwNP patients with mepolizumab and dupilumab, cytological examinations revealed an increase in the number of ciliated cells, a decrease in the number of eosinophils correlated with an improvement in the sense of smell on the VAS scale.
- Open Access
- 30 September 2024
- Published by Medical Education in OphthaTherapy. Therapies in Ophthalmology
- Vol. 11 (3) , 236-242
Is there a relationship between the microbiome of the paranasal sinuses and nasal cavity and the primary acquired nasolacrimal duct obstruction? Literature review
Hormonal factors, atopy, viral infections, gastroesophageal reflux, ischemic heart disease and swimming in a pool are believed to affect the development of primary acquired nasolacrimal duct obstruction (PANDO). It is suggested that patients with PANDO have more advanced inflammatory lesions revealed by the tomographic examination of the paranasal sinuses. The authors’ aim was to answer the question whether there is a connection between the chronic inflammation and disruption of the microbiome of the nasal cavity and sinuses and the development of inflammation in the lacrimal ducts. Pubmed.gov was the information source. Years reviewed included 2018 to 2023. Inclusion criteria included presence of an abstract, pathology of the nasolacrimal ducts, acute and chronic inflammation of the nasolacrimal ducts, papers written in English, studies on humans, publications regarding pathology of the lacrimal sac and paranasal sinuses, case report. The exclusion criteria included: lack of abstract, pathologies of other sections of the drainage system, pathology of the nasolacrimal ducts, other than chronic or acute inflammation, papers written in a language other than English, lack of case report. No gender criterion was used. Based on the data available in the literature, only 7 studies described the co-occurrence of pathologies of the lacrimal ducts and paranasal sinuses. Only 4 publications contained information on the microbiome and identified Streptococcus intermedius and Staphylococcus aureus, and in 2 cases no increase in pathological flora was revealed. The question about the relationship between the microbiome of the lacrimal sac and the paranasal sinuses and their mutual impact on the developing inflammation has not been answered, which, according to the authors, requires further research.
- 30 September 2024
- Published by Medical Education in OphthaTherapy. Therapies in Ophthalmology
- Vol. 11 (3) , 236-242
Open AccessIs there a relationship between the microbiome of the paranasal sinuses and nasal cavity and the primary acquired nasolacrimal duct obstruction? Literature review
Hormonal factors, atopy, viral infections, gastroesophageal reflux, ischemic heart disease and swimming in a pool are believed to affect the development of primary acquired nasolacrimal duct obstruction (PANDO). It is suggested that patients with PANDO have more advanced inflammatory lesions revealed by the tomographic examination of the paranasal sinuses. The authors’ aim was to answer the question whether there is a connection between the chronic inflammation and disruption of the microbiome of the nasal cavity and sinuses and the development of inflammation in the lacrimal ducts. Pubmed.gov was the information source. Years reviewed included 2018 to 2023. Inclusion criteria included presence of an abstract, pathology of the nasolacrimal ducts, acute and chronic inflammation of the nasolacrimal ducts, papers written in English, studies on humans, publications regarding pathology of the lacrimal sac and paranasal sinuses, case report. The exclusion criteria included: lack of abstract, pathologies of other sections of the drainage system, pathology of the nasolacrimal ducts, other than chronic or acute inflammation, papers written in a language other than English, lack of case report. No gender criterion was used. Based on the data available in the literature, only 7 studies described the co-occurrence of pathologies of the lacrimal ducts and paranasal sinuses. Only 4 publications contained information on the microbiome and identified Streptococcus intermedius and Staphylococcus aureus, and in 2 cases no increase in pathological flora was revealed. The question about the relationship between the microbiome of the lacrimal sac and the paranasal sinuses and their mutual impact on the developing inflammation has not been answered, which, according to the authors, requires further research.
- 25 April 2024
- Published by "Medycyna Praktyczna" Spolka Jawna in Polish Archives of Internal Medicine
- Vol. 134 (5)
The relationship between blood eosinophilia and disease severity in chronic rhinosinusitis with nasal polyps
DOI: 10.20452/pamw.16740, Published online: April 25, 2024, Authors: Grażyna Stryjewska-Makuch, Maria Humeniuk-Arasiewicz, Magdalena Kokoszka, Karolina Goroszkiewicz, Joanna Gluck
- 25 April 2024
- Published by "Medycyna Praktyczna" Spolka Jawna in Polish Archives of Internal Medicine
- Vol. 134 (5)
The relationship between blood eosinophilia and disease severity in chronic rhinosinusitis with nasal polyps
DOI: 10.20452/pamw.16740, Published online: April 25, 2024, Authors: Grażyna Stryjewska-Makuch, Maria Humeniuk-Arasiewicz, Magdalena Kokoszka, Karolina Goroszkiewicz, Joanna Gluck
- Open Access
- 3 August 2023
- Published by S. Karger AG in International Archives of Allergy and Immunology
- Vol. 184 (9) , 856-865
Allergic Fungal Rhinosinusitis in Europe: Literature Review and Own Experience
Allergic fungal rhinosinusitis (AFRS) is primary, Th2-mediated, chronic rhinosinusitis, which is diagnosed when the criteria defined by Bent and Khun are met. The disease is most common in countries located in the subtropical and tropical regions characterized by high temperatures and high levels of humidity, which favour the wider occurrence of fungi in the environment. The presence of specific IgE antibodies directed against fungal allergens, which is one of the diagnostic criteria, proves the systemic nature of the disease and allows one to distinguish AFRS from eosinophilic fungal rhinosinusitis. There is no unified treatment method for AFRS described in the literature, and relapses are common. Sinus surgery remains the treatment of choice. Oral and topical steroid therapy plays an important role in the treatment process. The effectiveness of antifungal treatment and immunotherapy is unclear. Biological treatment, the results of which are promising, has raised great hopes. The aim of this study was to reveal how often AFRS occurs in European countries, what environmental factors influence its development, and how important it is to specify its diagnostic criteria and treatment methods. We present an overview of the available literature. In addition, we share our own experience and describe two cases of AFRS diagnosed and treated at our centre.
- 3 August 2023
- Published by S. Karger AG in International Archives of Allergy and Immunology
- Vol. 184 (9) , 856-865
Open AccessAllergic Fungal Rhinosinusitis in Europe: Literature Review and Own Experience
Allergic fungal rhinosinusitis (AFRS) is primary, Th2-mediated, chronic rhinosinusitis, which is diagnosed when the criteria defined by Bent and Khun are met. The disease is most common in countries located in the subtropical and tropical regions characterized by high temperatures and high levels of humidity, which favour the wider occurrence of fungi in the environment. The presence of specific IgE antibodies directed against fungal allergens, which is one of the diagnostic criteria, proves the systemic nature of the disease and allows one to distinguish AFRS from eosinophilic fungal rhinosinusitis. There is no unified treatment method for AFRS described in the literature, and relapses are common. Sinus surgery remains the treatment of choice. Oral and topical steroid therapy plays an important role in the treatment process. The effectiveness of antifungal treatment and immunotherapy is unclear. Biological treatment, the results of which are promising, has raised great hopes. The aim of this study was to reveal how often AFRS occurs in European countries, what environmental factors influence its development, and how important it is to specify its diagnostic criteria and treatment methods. We present an overview of the available literature. In addition, we share our own experience and describe two cases of AFRS diagnosed and treated at our centre.
- Open Access
- 18 October 2022
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 280 (2) , 519-527
What may surprise a rhinologist in everyday clinical practice: silent sinus syndrome or pneumosinus dilatans/pneumocele? Literature review and own experience
Background: The aim of the study was to present rare sinus syndromes known as silent sinus syndrome (SSS) and frontal sinus syndrome with excessive pneumatization and bone defects in the wall (pneumocele). The available literature describing pneumocele cases was reviewed. Methodology: PubMed and Science Direct databases were searched by two independent reviewers. The primary outcome was finding descriptions of the sinus pneumocele. In the end, papers on frontal sinus pneumocele that was not the result of trauma, congenital defects or comorbidities were selected. Moreover, the authors presented their own cases of SSS and pneumocele. Results: Twelve case reports of frontal sinus pneumocele were found, one own case was presented. In addition, 8 subjects with SSS, diagnosed and treated in the period from September 2017 to May 2022, were described. Conclusions: With the increasing number of patients suffering from sinus diseases and the growing number of endoscopic surgeries, the knowledge of rare sinus syndromes will increase the safety of the procedures performed.
- 18 October 2022
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 280 (2) , 519-527
Open AccessWhat may surprise a rhinologist in everyday clinical practice: silent sinus syndrome or pneumosinus dilatans/pneumocele? Literature review and own experience
Background: The aim of the study was to present rare sinus syndromes known as silent sinus syndrome (SSS) and frontal sinus syndrome with excessive pneumatization and bone defects in the wall (pneumocele). The available literature describing pneumocele cases was reviewed. Methodology: PubMed and Science Direct databases were searched by two independent reviewers. The primary outcome was finding descriptions of the sinus pneumocele. In the end, papers on frontal sinus pneumocele that was not the result of trauma, congenital defects or comorbidities were selected. Moreover, the authors presented their own cases of SSS and pneumocele. Results: Twelve case reports of frontal sinus pneumocele were found, one own case was presented. In addition, 8 subjects with SSS, diagnosed and treated in the period from September 2017 to May 2022, were described. Conclusions: With the increasing number of patients suffering from sinus diseases and the growing number of endoscopic surgeries, the knowledge of rare sinus syndromes will increase the safety of the procedures performed.